S100B and myeloid sarcoma: Altogether, our results suggest that the high S100B levels released upon demyelination may engage the RAGE pathway contributing to MS pathogenesis, including impaired oligodendrogenesis and remyelination failure, neuronal loss and synaptic dysfunction, as well as glia activation with excessive neuroinflammatory microenvironment.